Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | NAMPT | P43490 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.44 |
| ▸ | DRD2 | P14416 | 2/20 | 0.43 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | PIM1 | P11309 | 1/20 | 0.43 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.43 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.43 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.41 |
| ▸ | CKS1B | P61024 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7006038 | 0.89 | EPHX2 (0.54) | EPHX2NAMPTKMT2AL3MBTL1MTNR1A | |
| SCHEMBL7003843 | 0.87 | EPHX2 (0.54) | EPHX2NAMPTKMT2AL3MBTL1MTNR1A | |
| SCHEMBL12679645 | 0.87 | EPHX2 (0.54) | EPHX2NAMPTKMT2AL3MBTL1MTNR1A | |
| SCHEMBL2981090 | 0.84 | HPGD (0.52) | ALDH1A1HPGDKMT2AMTNR1AMTNR1B | |
| SCHEMBL2517874 | 0.81 | MTNR1A (0.67) | EPHX2NAMPTKMT2AL3MBTL1MTNR1A | |
| SCHEMBL30576518 | 0.81 | MTNR1A (0.67) | EPHX2NAMPTKMT2AL3MBTL1MTNR1A | |
| SCHEMBL8564093 | 0.81 | EPHX2 (0.47) | EPHX2NAMPTKMT2AL3MBTL1MTNR1A | |
| SCHEMBL8564090 | 0.81 | EPHX2 (0.47) | EPHX2NAMPTKMT2AL3MBTL1MTNR1A | |
| SCHEMBL8566397 | 0.81 | EPHX2 (0.47) | EPHX2NAMPTKMT2AL3MBTL1MTNR1A | |
| SCHEMBL27057854 | 0.81 | EPHX2 (0.51) | EPHX2NAMPTKMT2AL3MBTL1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8273754-B2 | Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds | ARQULE, INC. (US) | 2012-09-25 | — | — | US | disclosed |
| US-8273754-B2 | Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds | ARQULE, INC. (US) | 2012-09-25 | — | — | US | disclosed |
| EP-2379556-A1 | SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS | ArQule, Inc. (US) | 2011-10-26 | — | — | EP | disclosed |
| WO-2010078430-A1 | SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS | ARQULE, INC. (US) | 2010-07-08 | — | — | WO | disclosed |
| WO-2010078430-A1 | SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS | ARQULE, INC. (US) | 2010-07-08 | — | — | WO | disclosed |
| US-20100172867-A1 | SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS | ARQULE, INC. (US) | 2010-07-08 | — | — | US | disclosed |
| US-20100172867-A1 | SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS | ARQULE, INC. (US) | 2010-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100172867-A1 | SUBSTITUTED 1H-PYRAZOLO[3,4-D]PYRIMIDINE-6-AMINE COMPOUNDS | DPYD, MKI67, TYMP | EPHX2 1854/4885NAMPT 192/4885ALDH1A1 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.